Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 4/20 | 0.47 |
| ▸ | CCR5 | P51681 | 12/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KIT | P10721 | 1/20 | 0.33 |
| ▸ | FLT3 | P36888 | 1/20 | 0.33 |
| ▸ | CCR7 | P32248 | 1/20 | 0.33 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7218136 | 0.96 | CCR2 (0.49) | CCR2CCR5L3MBTL1NPC1ALDH1A1 | |
| SCHEMBL7221638 | 0.95 | CCR2 (0.49) | CCR2CCR5L3MBTL1KITFLT3 | |
| SCHEMBL7166194 | 0.95 | CCR2 (0.49) | CCR2CCR5L3MBTL1NPC1ALDH1A1 | |
| SCHEMBL3036593 | 0.93 | CCR2 (0.56) | CCR2CCR5CCR7CXCR3 | |
| SCHEMBL30227439 | 0.93 | CCR2 (0.56) | CCR2CCR5CCR7CXCR3 | |
| Hydrochloric Acid SCHEMBL7931139 | 0.93 | CCR2 (0.55) | CCR2CCR5CCR7CXCR3 | |
| SCHEMBL7222727 | 0.92 | CCR2 (0.44) | CCR2CCR5L3MBTL1SMN1; SMN2CCR7 | |
| SCHEMBL7171409 | 0.92 | CCR2 (0.51) | CCR2CCR5NPC1ALDH1A1MAPT | |
| SCHEMBL7165818 | 0.91 | CCR2 (0.49) | CCR2CCR5L3MBTL1NPC1ALDH1A1 | |
| SCHEMBL7222634 | 0.91 | CCR2 (0.44) | CCR2CCR5L3MBTL1KITFLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6627651-B1 | Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2003-09-30 | — | — | US | claimed |
| EP-1182195-A1 | CYCLIC COMPOUNDS AND USES THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2002-02-27 | — | — | EP | claimed |
| US-6627651-B1 | Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2003-09-30 | — | — | US | disclosed |
| EP-1182195-A1 | CYCLIC COMPOUNDS AND USES THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2002-02-27 | — | — | EP | disclosed |